Pyle Laura, Choi Ye Ji, Narongkiatikhun Phoom, Sharma Kumar, Waikar Sushrut, Layton Anita, Tommerdahl Kalie L, de Boer Ian, Vigers Timothy, Nelson Robert G, Lynch Jane, Brosius Frank, Saulnier Pierre J, Goodrich Jesse A, Tryggestad Jeanie B, Isganaitis Elvira, Bacha Fida, Nadeau Kristen J, van Raalte Daniel, Kretzler Matthias, Heerspink Hiddo, Bjornstad Petter
Section of Pediatric Endocrinology, Department of Pediatrics, University of Colorado School of Medicine, Aurora, Colorado.
Department of Biostatistics and Informatics, Colorado School of Public Health, Aurora, Colorado.
Clin J Am Soc Nephrol. 2024 Dec 1;19(12):1603-1612. doi: 10.2215/CJN.0000000000000559. Epub 2024 Oct 21.
Proteomics analyses identified seven proteins predictive of time to development of albuminuria among youth with type 2 diabetes in the Treatment Options for Type 2 Diabetes in Adolescents and Youth cohort, 118 proteins predictive of time to development of hyperfiltration, and three proteins predictive of time to rapid eGFR decline. Seven proteins were predictive of all three outcomes (SEM4A, PSB3, dihydroxyphenylalanine decarboxylase, C1RL1, T132A, pyruvate carboxylase, and C1-esterase inhibitor) and have been implicated in immune regulatory mechanisms, metabolic dysregulation, proteostasis, and cellular signaling pathways. Elastic net Cox proportional hazards model identified distinct multiprotein signatures (38–68 proteins) of time to albuminuria, hyperfiltration, and rapid eGFR decline with concordance for models with clinical covariates and selected proteins between 0.81 and 0.96, whereas the concordance for models with clinical covariates only was between 0.56 and 0.63.
The onset of diabetic kidney disease (DKD) in youth with type 2 diabetes (T2D) mellitus often occurs early, leading to complications in young adulthood. Risk biomarkers associated with the early onset of DKD are urgently needed in youth with T2D.
We conducted an in-depth analysis of 6596 proteins (SomaScan 7K) in 374 baseline plasma samples from the Treatment Options for Type 2 Diabetes in Adolescents and Youth study to identify multiprotein signatures associated with the onset of albuminuria (urine albumin-to-creatinine ratio ≥30 mg/g), a rapid decline in eGFR (annual eGFR decline >3 ml/min per 1.73 m and/or ≥3.3% at two consecutive visits), and hyperfiltration (≥135 ml/min per 1.73 m at two consecutive visits). Elastic net Cox regression with ten-fold cross-validation was applied to the top 100 proteins (ranked by value) to identify multiprotein signatures of time to development of DKD outcomes.
Participants in the Treatment Options for Type 2 Diabetes in Adolescents and Youth study (14±2 years, 63% female, 7±6 months diabetes duration) experienced high rates of early DKD: 43% developed albuminuria, 48% hyperfiltration, and 16% rapid eGFR decline. Increased levels of seven and three proteins were predictive of shorter time to develop albuminuria and rapid eGFR decline, respectively; 118 proteins predicted time to development of hyperfiltration. Elastic net Cox proportional hazards models identified multiprotein signatures of time to incident early DKD with concordance for models with clinical covariates and selected proteins between 0.81 and 0.96, whereas the concordance for models with clinical covariates only was between 0.56 and 0.63.
Our research sheds new light on proteomic changes early in the course of youth-onset T2D that associate with DKD. Proteomic analyses identified promising risk factors that predict DKD risk in youth with T2D and could deepen our understanding of DKD mechanisms and potential interventions.
: NCT00081328.
蛋白质组学分析在青少年和青年2型糖尿病治疗选择队列中,识别出7种可预测2型糖尿病青年出现蛋白尿时间的蛋白质、118种可预测出现超滤时间的蛋白质以及3种可预测估算肾小球滤过率(eGFR)快速下降时间的蛋白质。7种蛋白质可预测所有这三种结局(SEM4A、PSB3、二羟基苯丙氨酸脱羧酶、C1RL1、T132A、丙酮酸羧化酶和C1酯酶抑制剂),并且与免疫调节机制、代谢失调、蛋白质稳态及细胞信号通路有关。弹性网Cox比例风险模型识别出了出现蛋白尿、超滤和eGFR快速下降时间的不同多蛋白特征(38 - 68种蛋白质),包含临床协变量和选定蛋白质的模型之间的一致性在0.81至0.96之间,而仅包含临床协变量的模型之间的一致性在0.56至0.63之间。
2型糖尿病(T2D)青年患者的糖尿病肾病(DKD)通常发病较早,会导致青年期出现并发症。T2D青年患者迫切需要与DKD早期发病相关的风险生物标志物。
我们对青少年和青年2型糖尿病治疗选择研究中374份基线血浆样本中的6596种蛋白质(SomaScan 7K)进行了深入分析,以识别与蛋白尿(尿白蛋白与肌酐比值≥30 mg/g)、eGFR快速下降(每年eGFR下降>3 ml/min/1.73 m²且/或连续两次就诊时≥3.3%)和超滤(连续两次就诊时≥135 ml/min/1.73 m²)发病相关的多蛋白特征。对排名前100的蛋白质(按 值排序)应用带十倍交叉验证的弹性网Cox回归,以识别出现DKD结局时间的多蛋白特征。
青少年和青年2型糖尿病治疗选择研究的参与者(14±2岁,63%为女性,糖尿病病程7±6个月)早期DKD发生率较高:43%出现蛋白尿,48%出现超滤,16%出现eGFR快速下降。7种和3种蛋白质水平升高分别可预测出现蛋白尿和eGFR快速下降的时间缩短;118种蛋白质可预测出现超滤的时间。弹性网Cox比例风险模型识别出了新发早期DKD时间的多蛋白特征,包含临床协变量和选定蛋白质的模型之间的一致性在0.81至0.96之间,而仅包含临床协变量的模型之间的一致性在0.56至0.63之间。
我们的研究揭示了青年期发病的T2D病程早期与DKD相关的蛋白质组学变化。蛋白质组学分析识别出了有前景的风险因素,可预测T2D青年患者的DKD风险,并能加深我们对DKD机制及潜在干预措施的理解。
NCT00081328。